CareTrust REIT, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTRE research report →
Range $43 – $47
Price Chart
About the company
CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, seniors' housing complexes, and other related medical real estate.
- CEO
- David Sedgwick
- IPO
- 2014
- Employees
- 43
- HQ
- Dana Point, CA, US
Get TickerSpark's AI analysis on CTRE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $9.39B
- P/E
- 25.01
- Fwd P/E
- 26.31
- PEG
- 0.80
- P/S
- 17.28
- P/B
- 2.07
- EV/EBITDA
- 19.98
- Div Yield
- 3.65%
- Gross Margin
- 77.98%
- Op Margin
- 69.70%
- Net Margin
- 65.40%
- ROE
- 8.54%
- ROIC
- 6.46%
Latest fiscal year · YoY change
- Revenue
- $476.59M+108.8%
- Gross Profit
- $281.79M+31.2%
- Op Income
- $320.14M
- Net Income
- $320.54M+156.3%
- EPS
- $1.57+93.8%
- OCF Growth
- +61.3%
- FCF Growth
- +60.5%
- 52W High
- $43.62
- 52W Low
- $32.79
- 50D MA
- $40.26
- 200D MA
- $38.77
- Beta
- 0.80
- RSI (14)
- 45
- Avg Volume
- 2.74M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
CareTrust reported record quarterly results, raised full-year guidance, and said its investment pipeline remains active across skilled nursing, U.K. care homes, loans, and SHOP.· August 7, 2026
- Q2 featured record investments, revenue, and FFO per share, with about $900 million invested at an 8.9% blended stabilized yield.
- Normalized FFO rose 44% year over year to $119.7 million, and normalized FAD rose 43% to $118.5 million; per-share FFO and FAD were both $0.51, up about 19%.
- Management raised full-year 2026 guidance to normalized FFO per share of $2.03-$2.06 and normalized FAD per share of $2.01-$2.04.
- Year to date, CareTrust has closed about $1.5 billion of investments, and the current pipeline is about $540 million, with roughly two-thirds skilled nursing and one-third loans plus U.K. care homes.
- Balance sheet leverage remains very low at 1.0x net debt to annualized normalized run-rate EBITDA, with about $1.4 billion of liquidity and no scheduled debt maturities before 2028.
For Q2 2026, normalized FFO increased 44% year over year to $119.7 million, and normalized FAD increased 43% to $118.5 million. Normalized FFO per share was $0.51, up about 19% from the prior-year quarter, and normalized FAD per share was also $0.51, up about 19%. The company said it completed approximately $900 million of investments in the quarter at a blended stabilized yield of 8.9%. Management raised full-year 2026 guidance to normalized FFO per share of $2.03-$2.06 and normalized FAD per share of $2.01-$2.04, implying midpoint growth of 16.2% and about 15.1%, respectively, versus full-year 2025. Liquidity was about $1.4 billion, including approximately $90 million of cash, $605 million of revolver availability, and about $671 million of unsettled equity forward proceeds; net debt to annualized normalized run-rate EBITDA was 1.0x and fixed charge coverage was 9.9x.
David Sedgwick framed the quarter as evidence that CareTrust’s long-running investment “flywheel” is accelerating, calling Q2 a record quarter for investments, revenue, and FFO per share. He repeatedly emphasized operator quality and lease coverage as the foundation of the model, saying the company prefers to pass on deals rather than compromise on operator quality. His tone was highly confident and upbeat, and he said CareTrust is “super bullish” on where the company is headed.
Derek Bunker focused on the financial upside from the investment pace and the company’s funding capacity. He highlighted Q2 normalized FFO of $119.7 million, normalized FAD of $118.5 million, the equity forward raises of $580.5 million in-quarter and $90.6 million since quarter end, and the remaining 16.6 million unsettled shares representing about $671.4 million of gross proceeds. He said the updated guidance assumes no additional investments or financings beyond year-to-date activity, 2.5% inflation-based rent escalators, $147 million of loan repayments, and no material change in GBP/USD; he also pointed to strong liquidity, 1.0x leverage, 9.9x fixed charge coverage, and no debt maturities before 2028.
Analysts focused on SHOP, asking why CareTrust’s SHOP activity has been slower than some peers, and management said it comes down mostly to pricing and discipline rather than lack of interest. James Callister said SHOP cap rates can compress into the mid- to low-5s, while SNF and other opportunities can still offer returns in the 8s or 9s, so CareTrust is choosing risk-adjusted returns over volume. Questions also covered U.K. scale deals, portfolio concentration, possible tenant conversions to SHOP, PACS, purchase options, financing receivables, and regulatory risk; management generally responded that it is staying selective, sees room to grow with strong operators, and views the skilled nursing environment as stable.
The positive case from this call is that CareTrust is still finding a large volume of attractive transactions while keeping leverage low and liquidity high. Management believes its operator-first underwriting is producing above-industry care metrics and supporting durable lease coverage, which should underpin future growth and rent resets starting in 2031. The company also sees more room to expand in the U.K., in SHOP selectively, and through loans that can lead to future real estate acquisitions.
The main risk discussed was that SHOP remains harder to scale because competition is intense and pricing can get too rich to meet CareTrust’s return hurdles. Management also acknowledged that some purchase options and loan-to-own structures could unwind into asset sales or delayed real estate ownership, creating uncertainty around timing. More broadly, the company said it is disciplined enough to walk away from deals, which is good for returns but means growth could slow if the pipeline or pricing weakens.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.2%
- Shares Outstanding
- 236.24M
- Float Shares
- 234.30M
of shares held by institutions
494 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CTRE, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Daniel GoldmanHouse · NY10 | Sell | Jul 12, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 40.73M | ▲ 4.85M |
| Vanguard Group Inc | 33.18M | ▲ 210.97K |
| Cohen & Steers, Inc. | 12.75M | ▲ 768.24K |
| State Street Corp | 12.45M | ▲ 412.27K |
| Vanguard Capital Management LLC | 10.64M | ▲ 637.64K |
| Fmr LLC | 10.51M | ▲ 466.29K |
| T. Rowe Price Investment Management, Inc. | 10.13M | ▲ 1.21M |
| Wellington Management Group Llp | 9.70M | ▼ 2.13M |
| Geode Capital Management, LLC | 7.49M | ▲ 503.75K |
| Nuveen, LLC | 5.03M | ▲ 591.34K |
| Sixth Street Partners Management Company, L.P. | 4.68M | ▲ 4.68M |
| Charles Schwab Investment Management Inc | 4.68M | ▲ 417.80K |
Held by 417 ETFs
Biggest fund positions in CTRE by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 31, 26 | BEALE LAUREN | other | 12,208 |
| Jan 31, 26 | Callister James | other | 58,379 |
| Jan 31, 26 | Callister James | other | 46,267 |
| Jan 31, 26 | Sedgwick David M. | other | 99,240 |
| Jan 31, 26 | Sedgwick David M. | other | 114,274 |
| Jan 2, 26 | Stapley Gregory K. | other | 5,781 |
| Jan 2, 26 | Williams Careina D. | other | 3,105 |
| Jan 2, 26 | Plumb Spencer G | other | 5,781 |
| Jan 2, 26 | Olson Anne | other | 3,105 |
| Jan 2, 26 | LAING DIANA | other | 3,105 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CTRE coverage
Recent articles, reports, and earnings notes.
No research on CTRE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CTRE report →Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More
247wallst.com · Aug 14
CareTrust REIT Q2 Earnings Call Highlights
marketbeat.com · Aug 7
CareTrust REIT, Inc. (CTRE) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 7
CareTrust REIT (CTRE) Meets Q2 FFO Estimates
zacks.com · Aug 6
CareTrust REIT Announces Second Quarter 2026 Operating Results; Increases 2026 Guidance
businesswire.com · Aug 6
California State Teachers Retirement System Buys 55,368 Shares of CareTrust REIT, Inc. $CTRE
defenseworld.net · Aug 4
REIT Rally: 3 Strong Buys With Average 1-Year Return Above 50%
seekingalpha.com · Jul 28
California Public Employees Retirement System Reduces Stock Position in CareTrust REIT, Inc. $CTRE
defenseworld.net · Jul 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.